These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27824642)

  • 1. Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Ungprasert P
    Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):e8-e12. PubMed ID: 27824642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies.
    Hayat U; Siddiqui AA; Okut H; Afroz S; Tasleem S; Haris A
    Ann Hepatol; 2021; 20():100254. PubMed ID: 32920163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
    Marventano S; Salomone F; Godos J; Pluchinotta F; Del Rio D; Mistretta A; Grosso G
    Clin Nutr; 2016 Dec; 35(6):1269-1281. PubMed ID: 27060021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.
    Ebadi M; Ip S; Bhanji RA; Montano-Loza AJ
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Jaruvongvanich V; Ahuja W; Wijarnpreecha K; Ungprasert P
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):694-697. PubMed ID: 28252464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease.
    Chen YP; Lu FB; Hu YB; Xu LM; Zheng MH; Hu ED
    Clin Nutr; 2019 Dec; 38(6):2552-2557. PubMed ID: 30573353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis.
    Kositamongkol C; Kanchanasurakit S; Auttamalang C; Inchai N; Kabkaew T; Kitpark S; Chaiyakunapruk N; Duangjai A; Saokaew S; Phisalprapa P
    Front Pharmacol; 2021; 12():786596. PubMed ID: 34966282
    [No Abstract]   [Full Text] [Related]  

  • 8. Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Edmonds PJ; Cheungpasitporn W
    QJM; 2016 Jul; 109(7):461-466. PubMed ID: 26385233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Boonpheng B; Panjawatanan P; Sharma K; Ungprasert P; Pungpapong S; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):986-994. PubMed ID: 29787418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heavy Coffee Consumption and Risk of Pancreatitis: A Systematic Review and Meta-Analysis.
    Wijarnpreecha K; Panjawatanan P; Mousa OY; Cheungpasitporn W; Pungpapong S; Ungprasert P
    Dig Dis Sci; 2018 Nov; 63(11):3134-3140. PubMed ID: 30043284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
    Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study.
    Jaruvongvanich V; Wijarnpreecha K; Ungprasert P
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):629-634. PubMed ID: 28716600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Lekuthai N; Thongprayoon C; Cheungpasitporn W; Ungprasert P
    Liver Int; 2017 Jun; 37(6):906-918. PubMed ID: 27891768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic Fatty Liver Disease and Urolithiasis. A Systematic Review and Meta-Analysis.
    Wijarnpreecha K; Lou S; Panjawatanan P; Sanguankeo A; Pungpapong S; Lukens FJ; Ungprasert P
    J Gastrointestin Liver Dis; 2018 Dec; 27(4):427-432. PubMed ID: 30574625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection.
    Maurice JB; Patel A; Scott AJ; Patel K; Thursz M; Lemoine M
    AIDS; 2017 Jul; 31(11):1621-1632. PubMed ID: 28398960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis.
    Liu F; Wang X; Wu G; Chen L; Hu P; Ren H; Hu H
    PLoS One; 2015; 10(11):e0142457. PubMed ID: 26556483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Thongtan T; Deb A; Vutthikraivit W; Laoveeravat P; Mingbunjerdsuk T; Islam S; Islam E
    Indian J Gastroenterol; 2022 Apr; 41(2):119-126. PubMed ID: 35318571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coffee Consumption and the Progression of NAFLD: A Systematic Review.
    Sewter R; Heaney S; Patterson A
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease.
    Yesil A; Yilmaz Y
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1038-44. PubMed ID: 24024834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.